Live Breaking News & Updates on நாள்பட்ட நுரையீரல்|Page 7

Stay updated with breaking news from நாள்பட்ட நுரையீரல். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Pulmonary endarterectomy improves outcomes in patients with segmental disease


Pulmonary endarterectomy improves outcomes in patients with segmental disease
A new study, presented today at the AATS 101st Annual Meeting, found that patients treated surgically for segmental Chronic Thromboembolic Pulmonary Hypertension (CTEPH) had excellent outcomes with the vast majority doing very well in the long term without any additional treatment other than surgery.
In addition, the study found that the proportion of CTEPH patients with segmental disease increased dramatically during the study period - from 2005 to 2020. At the beginning of the study, roughly seven percent of patients were diagnosed with segmental disease. During the last five years of the study, the proportion rose to an average of 41 percent of patients. ....

Emily Henderson , University Of Toronto , Chronic Thromboembolic Pulmonary Hypertension Program , Annual Meeting , Chronic Thromboembolic Pulmonary Hypertension , Marc De Perrot , Pulmonary Hypertension , எமிலி ஹென்டர்சன் , பல்கலைக்கழகம் ஆஃப் டொராண்டோ , ஆண்டு சந்தித்தல் , மார்க் டி பர்ரொட் ,

Artificial super stool may be a game-changer in the treatment of chronic gut infections


Artificial super stool may be a game-changer in the treatment of chronic gut infections
The urgent need for human stool donations to treat chronic gut infections could soon be eased with innovative research to develop artificial super stool.
The collaborative research aims to create a new generation of microbial therapies that can replace donor-derived faecal microbiota transplantation (FMT).
Technology that replicates the complex community of microbes in the human gut will be manufactured in Australia as part of the project.
Australian microbiome biotechnology company BiomeBank, in collaboration with RMIT University, has secured $100,000 in funding from the Innovative Manufacturing Cooperative Research Centre (IMCRC) to develop the new bioreactor technology. ....

Matthew Young , Thomas Mitchell , Naba Dutta , Namita Choudhury , Srinivas Mettu , Emily Henderson , School Of Engineering , Melinda Gates Foundation , Innovative Manufacturing Cooperative Research Centre , Australian Research Discovery , Professor Namita Choudhury , Professor Naba Dutta , Discipline Leader , Chemical Engineering , Manufacturing Innovation Manager , Grand Challenges Exploration , Australian Research Council Funded Discovery , மேத்யூ இளம் , தாமஸ் மிட்செல் , நாபா தத்தா , எமிலி ஹென்டர்சன் , பள்ளி ஆஃப் பொறியியல் , மெலிண்டா வாயில்கள் அடித்தளம் , புதுமையானது உற்பத்தி கூட்டுறவு ஆராய்ச்சி மையம் , ஒழுக்கம் தலைவர் , இரசாயன பொறியியல் ,

LibriVox

LibriVox
librivox.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from librivox.org Daily Mail and Mail on Sunday newspapers.

Before Body Parts , First Book , Bible Old Will , Bible Christian , Tanakh Hebrew , முதல் நூல் , திருவிவிலியம் கிறிஸ்துவர் ,

Chronic SARS-CoV-2 infections favor viral adaptation, says study


Chronic SARS-CoV-2 infections favor viral adaptation, says study
The rollout of vaccines against the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), agent behind the notorious and catastrophic coronavirus disease 2019 (COVID-19) pandemic, was expected to help usher in the end of the extreme social and economic devastation associated with containment measures.
A new study, released as a preprint on the
medRxiv server, offers a look at how to keep these hopes alive in the current context of highly infectious variants, which often display immune escape mutations.
Natural selection and VOCs
The emergence of recent mutant strains, called variants of concern (VOCs), in the UK, South Africa and Brazil, has shattered expectations of a speedy end to the pandemic. Prominent vaccine makers are now stressing the need for repeated boosters after a year of the original course, or less, along with updated vaccines to overcome the loss of efficacy against the n ....

South Africa , United Kingdom , Liji Thomas , Coronavirus Disease Covid 19 , Ars Cov 2 , Convalescent Plasma , Ibonucleic Acid , Evere Acute Respiratory , Evere Acute Respiratory Syndrome , ஒன்றுபட்டது கிஂக்டம் ,